Jana Janoutová
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jana Janoutová has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Martina Kovalová
Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
2 shared publications - Nikol Gottfriedová
Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic
2 shared publications - Vladimir Janout
Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic
2 shared publications - Anton Pelikán
University of Ostrava, Czech Republic; University Hospital Ostrava, Czech Republic; Tomas Bata University, Czech Republic
1 shared publication - Demet Sengul
Department of Pathology, Faculty of Medicine, Giresun University, Giresun, Turkiye
1 shared publication - Eva Mrázková
Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 1 October 2024
- Published by Tsinghua University Press in Journal of Otology
- Vol. 19 (4) , 220-226
Assessment of sensory impairment in older adults with dementia
Background: Over 55 million people worldwide are living with dementia. The rate of cognitive decline increases with age, and loss of senses may be a contributing factor. Objectives: This study aimed to analyze hearing, olfactory function, and color vision in patients with dementia. Materials and methods: The sample comprised 40 patients with dementia and 37 cognitively normal controls aged 41-85 years. All participants underwent conventional pure-tone audiometry and a screening version of the Hearing Handicap Inventory for Adults, the Odorized Markers Test of olfactory function and the Ishihara color vision test. The effects of comorbidities and lifestyle factors were also assessed. Results: Patients with dementia had significantly worse hearing at almost all frequencies tested and significantly greater olfactory impairment than cognitively normal controls. Color vision impairment was found in less than 8% of the sample, with no significant difference between the groups. Impairment of two senses (hearing and olfaction) was significantly more common in patients with dementia than in controls. Conclusion: Individuals with dementia were found to have sensory decline, namely hearing and olfactory impairment. Color vision was rarely impaired in the sample. Participants with dementia tended to have more multisensory impairments than controls.
- 1 October 2024
- Published by Tsinghua University Press in Journal of Otology
- Vol. 19 (4) , 220-226
Open AccessAssessment of sensory impairment in older adults with dementia
Background: Over 55 million people worldwide are living with dementia. The rate of cognitive decline increases with age, and loss of senses may be a contributing factor. Objectives: This study aimed to analyze hearing, olfactory function, and color vision in patients with dementia. Materials and methods: The sample comprised 40 patients with dementia and 37 cognitively normal controls aged 41-85 years. All participants underwent conventional pure-tone audiometry and a screening version of the Hearing Handicap Inventory for Adults, the Odorized Markers Test of olfactory function and the Ishihara color vision test. The effects of comorbidities and lifestyle factors were also assessed. Results: Patients with dementia had significantly worse hearing at almost all frequencies tested and significantly greater olfactory impairment than cognitively normal controls. Color vision impairment was found in less than 8% of the sample, with no significant difference between the groups. Impairment of two senses (hearing and olfaction) was significantly more common in patients with dementia than in controls. Conclusion: Individuals with dementia were found to have sensory decline, namely hearing and olfactory impairment. Color vision was rarely impaired in the sample. Participants with dementia tended to have more multisensory impairments than controls.
- 9 April 2024
- Published by Index Copernicus in Otolaryngologia Polska
- Vol. 78 (2) , 1-17
Cognitive impairment, neurodegenerative disorders, and olfactory impairment: A literature review
Introduction: The early detection and diagnosis of dementia are of key importance in treatment, slowing disease progression, or suppressing symptoms. The possible role of changes in the sense of smell is considered with regard to potential markers for early detection of Alzheimer’s disease (AD). Materials and methods: A literature search was conducted using the electronic databases PubMed, Scopus, and Web of Science between May 30, 2022 and August 2, 2022. The term “dementia” was searched with keyword combinations related to olfaction. Results: A total of 1,288 records were identified through the database search. Of these articles, 49 were ultimately included in the analysis. The results showed the potential role of changes in the sense of smell as potential biomarkers for early detection of AD. Multiple studies have shown that olfactory impairment may be observed in patients with AD, PD, MCI, or other types of dementia. Even though smell tests are able to detect olfactory loss caused by neurodegenerative diseases, they cannot reliably distinguish between certain diseases. Conclusions: In individuals with cognitive impairment or neurodegenerative diseases, olfactory assessment has repeatedly been reported to be used for early diagnosis, but not for differential diagnosis.
- 9 April 2024
- Published by Index Copernicus in Otolaryngologia Polska
- Vol. 78 (2) , 1-17
Cognitive impairment, neurodegenerative disorders, and olfactory impairment: A literature review
Introduction: The early detection and diagnosis of dementia are of key importance in treatment, slowing disease progression, or suppressing symptoms. The possible role of changes in the sense of smell is considered with regard to potential markers for early detection of Alzheimer’s disease (AD). Materials and methods: A literature search was conducted using the electronic databases PubMed, Scopus, and Web of Science between May 30, 2022 and August 2, 2022. The term “dementia” was searched with keyword combinations related to olfaction. Results: A total of 1,288 records were identified through the database search. Of these articles, 49 were ultimately included in the analysis. The results showed the potential role of changes in the sense of smell as potential biomarkers for early detection of AD. Multiple studies have shown that olfactory impairment may be observed in patients with AD, PD, MCI, or other types of dementia. Even though smell tests are able to detect olfactory loss caused by neurodegenerative diseases, they cannot reliably distinguish between certain diseases. Conclusions: In individuals with cognitive impairment or neurodegenerative diseases, olfactory assessment has repeatedly been reported to be used for early diagnosis, but not for differential diagnosis.